| Market Cap | ₹9,436Cr |
| ROE | 49.51% |
| P/E Ratio(TTM) | 30.75 |
| EPS(TTM) | 184.83 |
| P/B Ratio | 15.23 |
| Dividend Yield | 2.20% |
| Industry P/E | 39.95 |
| Book Value | 373.34 |
| Debt to Equity | 0.01 |
| Face Value | 10 |
| Parent Organisation | Procter & Gamble Health Limited |
| Managing Director | Mr. Milind Thatte |
| Founded | 1967 |
| NSE Symbol | PGHL |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Abbott India | NA (0.00%) | 40.72 | ||
| GlaxoSmithKline Pharmaceuticals | NA (0.00%) | 43.92 | ||
| Pfizer | NA (0.00%) | 27.02 | ||
| Astrazeneca Pharma India | NA (0.00%) | 113.38 |